ArticleCerebellum (London, England)2026
Tremor and Craniofacial Dystonia Preceding Ataxia in SCA43: Expanding the Phenotypic Spectrum of MME-related Ataxia.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinocerebellar ataxia type 43 (SCA43) is a rare autosomal dominant ataxia caused by pathogenic variants in the MME gene and typically presents with late-onset gait ataxia and sensory neuropathy. Hyperkinetic movement disorders are uncommon, and prominent craniofacial orobuccolingual dystonia-dominant presentations have not been documented. We report a 63-year-old woman who developed progressive orobuccolingual dystonia and stereotypical choreiform movements of the right hand several years before the onset of gait ataxia. These involuntary movements significantly interfered with feeding and speech and were initially isolated, creating diagnostic uncertainty. Examination revealed prominent craniofacial dyskinesias, postural tremor, gait ataxia, and distal lower limbs vibration loss with otherwise normal sensory modalities. MRI showed chronic small-vessel changes without cerebellar atrophy, and nerve conduction studies were normal. Whole-exome sequencing identified a heterozygous MME exon 21 variant (NM_000902.4:c.2067C > A; p.Asn689Lys), classified as a variant of uncertain significance, which segregated with disease in two affected sisters and was present in a minimally symptomatic son with a long-standing mild head tremor, supporting autosomal dominant inheritance. The phenotype was notable for the temporal dissociation between involuntary movements and cerebellar signs, normal electrophysiology despite sensory impairment, and the absence of cerebellar atrophy on imaging. This case expands the clinical spectrum of SCA43 by demonstrating that a hyperkinetic movement disorder phenotype, including tremor, choreiform movements, and craniofacial dystonia, may precede overt cerebellar dysfunction by several years. Recognition of such atypical manifestations is essential to avoid misdiagnosis and to prompt timely genetic evaluation in patients presenting with mixed or unexplained movement disorders, particularly in the presence of a supportive family history.
Indexed as
Identifiers
42132968What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.